GenSight Biologics S.A. (LON:0RIM)
0.0788
-0.0025 (-3.02%)
At close: Feb 11, 2026
GenSight Biologics Revenue
GenSight Biologics had revenue of 48.00K EUR in the half year ending June 30, 2025, a decrease of -98.23%. This brings the company's revenue in the last twelve months to 945.00K, down -52.18% year-over-year. In the year 2024, GenSight Biologics had annual revenue of 2.63M, down -11.44%.
Revenue (ttm)
945.00K EUR
Revenue Growth
-52.18%
P/S Ratio
19.44
Revenue / Employee
72.69K EUR
Employees
13
Market Cap
15.75M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.63M | -339.00K | -11.44% |
| Dec 31, 2023 | 2.96M | -1.90M | -39.08% |
| Dec 31, 2022 | 4.87M | -2.84M | -36.89% |
| Dec 31, 2021 | 7.71M | 269.00K | 3.62% |
| Dec 31, 2020 | 7.44M | 2.53M | 51.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Videndum | 245.70M |
| Aseana Properties | 9.91M |
| Ground Rents Income Fund | 5.95M |
| Cadogan Energy Solutions | 5.32M |
| GSTechnologies | 1.59M |
| Kelso Group Holdings | 947.95K |
| IMC Exploration Group | 56.58K |
| Solvonis Therapeutics | 31.87K |